TLV Equity Snapshot
ORMP Weekly Equity Report
Oramed Pharmaceuticals Inc.
What the company does
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
What the weekly tape is saying
ORMP closed the latest completed week at 1,112 ILA. The 4-week return is 8292.5% and the 12-week return is 9511.1%. Trend Signal is active, Market Dynamics is 1.49. Setup signature: Balanced read with a 65/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 163.7 ILA
- Vs Trend Line
- 579.4%
- Fair Value
- 46.53 ILA
- Vs Fair Value
- 2289.9%
- 52W High
- 1,357 ILA
- 52W Low
- 6.64 ILA
- Drawdown
- -18.1%
- Range Position
- 81.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 30 weeks
- 52W Active Weeks
- 30
- 52W Active Breadth
- 57.7%
- Sector Scope
- IL Healthcare
- Sector Rank
- 11 of 51
- Sector Percentile
- 80.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IL Healthcare
- Tracked Peers
- 51
- 4W Rank
- 8 of 51
- Avg 1W
- -0.8%
- Avg 4W
- 1587.1%
- Trend Breadth
- 29.4%
- Positive MD
- 52.9%
IL Biotechnology
- Tracked Peers
- 15
- 4W Rank
- 3 of 15
- Avg 1W
- -1.8%
- Avg 4W
- 1691.9%
- Trend Breadth
- 33.3%
- Positive RS
- 26.7%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.49
- 4W MD Change
- 173.3%
- Relative Strength
- 1026.72
- 4W RS Change
- 4923.3%
- Expectation
- Undecided
- Probability
- 49.75%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 14.2K
- 13W Average
- 28.0K
- 52W Average
- 44.4K
- Vs 13W
- 0.5x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2484.9%
- 52W Volatility
- 1280.7%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 364.7% / -3.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- TLV
- Country
- IL
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- ILA
- Market Cap
- 458.8M
Opportunity signals
- Trend Signal is active with a 30-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Recent volatility is running well above the one-year baseline.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,112 ILA | 1.7% | 163.7 ILA | 46.53 ILA | 1.49 | 1026.72 | 14.2K | On |
| 5 Jun 2026 | 1,093 ILA | -7.7% | 126.9 ILA | 37.72 ILA | 1.55 | 1334.58 | 38.9K | On |
| 29 May 2026 | 1,184 ILA | -5.2% | 90.65 ILA | 28.93 ILA | 1.25 | 1947.36 | 30.1K | On |
| 22 May 2026 | 1,249 ILA | 9326.4% | 51.43 ILA | 19.22 ILA | 0.99 | 3488.77 | 31.7K | On |
| 15 May 2026 | 13.25 ILA | 12.4% | 10.05 ILA | 8.80 ILA | 0.54 | 20.44 | 74.3K | On |
| 8 May 2026 | 11.79 ILA | 2.5% | 9.84 ILA | 8.76 ILA | 0.16 | 4.16 | 17.7K | On |
| 1 May 2026 | 11.50 ILA | 0.6% | 9.71 ILA | 8.74 ILA | -0.03 | 3.36 | 58.8K | On |
| 24 Apr 2026 | 11.43 ILA | -2.2% | 9.60 ILA | 8.71 ILA | -0.29 | 3.74 | 17.3K | On |
| 17 Apr 2026 | 11.69 ILA | 7.6% | 9.48 ILA | 8.69 ILA | -0.31 | 4.51 | 31.0K | On |
| 10 Apr 2026 | 10.86 ILA | 3.3% | 9.33 ILA | 8.66 ILA | -0.24 | -4.14 | 6.8K | On |
| 3 Apr 2026 | 10.51 ILA | -3.8% | 9.23 ILA | 8.64 ILA | -0.17 | -2.17 | 5.9K | On |
| 27 Mar 2026 | 10.93 ILA | -5.5% | 9.11 ILA | 8.63 ILA | 0.03 | 3.34 | 12.6K | On |
| 20 Mar 2026 | 11.57 ILA | 10.7% | 8.99 ILA | 8.61 ILA | 0.22 | 3.38 | 25.0K | On |
| 13 Mar 2026 | 10.45 ILA | -5.7% | 8.83 ILA | 8.58 ILA | 0.14 | -4.12 | 45.4K | On |